R&D Trends

Accenture, Oracle expand Life Sciences Cloud for R&D

Friday, April 24, 2015 01:14 PM

Accenture, a global management consulting, technology services and outsourcing company, has expanded the Accenture Life Sciences Cloud for R&D, powered by Oracle, with the addition of enhanced clinical data management capabilities. This enables life sciences companies to generate high-quality, reliable and statistically sound data from clinical trials to reduce the time, effort and cost needed to take drugs from development to market.

More... »

Quest Diagnostics

Curadev, Roche ink research cancer immunotherapeutic collaboration

Wednesday, April 22, 2015 12:13 PM

Curadev Pharma, headquartered in New Delhi, India, has entered into a research collaboration and exclusive license agreement with Roche for the development and commercialization of IDO1 and TDO inhibitors. The agreement covers the development of the lead preclinical immune tolerance inhibitor and a research collaboration with Roche's research and early development organization to further explore the IDO and TDO pathways.

More... »


Takeda collaborates with Keio University, Niigata University

Wednesday, April 22, 2015 11:58 AM

Takeda Pharmaceutical has signed an agreement to undertake collaborative research with Keio University School of Medicine (Shinjuku Ward, Tokyo) and Niigata University (Niigata City, Niigata) at Takeda’s Shonan Research Center (Fujisawa City, Kanagawa) regarding the search for and functional analysis of disease-related RNA-binding proteins. This may lead to treatments in CNS and oncology.

More... »

Immunocore, MedImmune collaborate on immuno-oncology combination trials

Friday, April 17, 2015 12:36 PM

Immunocore, a biotechnology company developing novel biological drugs to treat cancer and other diseases headquartered outside Oxford, England, and MedImmune, the global biologics R&D arm of AstraZeneca, have entered into a second collaboration.

More... »

Veracyte, GE collaborate to improve disease diagnosis

Wednesday, April 15, 2015 12:54 PM

Veracyte, a South San Francisco, Calif.-based molecular diagnostic company pioneering the field of molecular cytology, and GE, focused on software, advanced manufacturing, energy and healthcare, have formed a research collaboration to develop new solutions that can improve disease diagnosis. Financial and other terms have not been disclosed.

More... »

Study: 2014 a record-setting year for U.S. medicines

Wednesday, April 15, 2015 12:44 PM

Total spending on U.S. medicines increased 10.3% on a real per capita basis to $373.9 billion in 2014, with a record volume of 4.3 billion prescriptions filled. The year also marked the highest number of transformative medicines launched in more than a decade, according to a new report issued by the IMS Institute for Healthcare Informatics. IMS Health is a global information and technology services company based in Parsippany, N.J.

More... »

HHS to award $1M in new grant programs to improve sharing of health information

Wednesday, April 15, 2015 12:37 PM

Health and Human Services has made available $1 million in grant funds to support community projects for the Community Interoperability Health Information Exchange (HIE) Program. The funding will help support and enable the flow of health information at the community level, leading to better care and better health.

More... »

NIH, South African Medical Research Council award $8M in HIV, TB grants

Monday, April 13, 2015 12:23 PM

The NIH and the South African Medical Research Council (SAMRC) are awarding 31 grants to U.S. and South African scientists to support research targeting HIV/AIDS, tuberculosis and HIV-related co-morbidities and cancers.

More... »

Medivir, Cancer Research Technology collaborate to develop new class of cancer drugs

Monday, April 13, 2015 12:15 PM

Medivir, a research-based pharmaceutical company based in Sweden, and Cancer Research Technology (CRT), Cancer Research U.K.’s commercialization and development arm, have partnered to develop a new class of drugs that has shown promise for treating a range of different cancers, including pancreatic cancer.

More... »

BioXcel, Takeda partner to repurpose assets for orphan diseases

Friday, April 10, 2015 01:45 PM

BioXcel, a Branford, Conn.-based provider of cloud-based pharma big data solutions for discovering novel products, has partnered with Takeda Development Center Americas for the repurposing of assets across the gamut of rare diseases.

More... »

CWWeekly

April 20

Christie Clinic, PMG Research's 12th clinical research site, expands its geographic reach north to Illinois

Clinipace acquires Accovion to expand European presence, following an infusion of equity that could lead to more deals

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

PSI, INC Research, Chiltern best with sites
Strategic outsourcing prioritizing, improving site relationships

Regulatory compliance an increasing burden on sites
Increased staff time, materials, storage eroding site operating profit

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs